Showing results (171-180 of 435) with videos related to
Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injuryMichael J Overman, Dipen M Maru, Chusilp Charnsangavej, et al.BMC Cancer|September 11, 2020
Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer developmentJennifer S Davis, Preeti Kanikarla-Marie, Mihai Gagea, et al.JAMA|December 3, 2009
Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastasesYun Shin Chun, Jean-Nicolas Vauthey, Piyaporn Boonsirikamchai, et al.Journal of the American College of Surgeons|June 10, 2021
Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal CancerYoshikuni Kawaguchi, Scott Kopetz, Lawrence Kwong, et al.JCO Precision Oncology|September 11, 2020
Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced CancersScott Kopetz, Kenna R Mills Shaw, J Jack Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastasesJunichi Shindoh, Evelyne M Loyer, Scott Kopetz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastasesSusan B Kesmodel, Lee M Ellis, E Lin, et al.Frontiers in Oncology|July 9, 2020
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian CancerKristen P Zeligs, Maria Pia Morelli, Justin M David, et al.Clinical Colorectal Cancer|July 29, 2019
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal CancerCharalampos S Floudas, Gagandeep Brar, Donna Mabry-Hrones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcomeAntoine Brouquet, Eddie K Abdalla, Scott Kopetz, et al.Pageof 44